| Dr Stephen E Smith, MD | |
|
4225 Evans Ave, Fort Myers, FL 33901-9311 | |
| (239) 936-8655 | |
| (239) 936-8683 |
| Full Name | Dr Stephen E Smith |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 31 Years |
| Location | 4225 Evans Ave, Fort Myers, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366438855 | NPI | - | NPPES |
| 254549702 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME75617 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Associates Of Southwest Florida Md Pa | 7810234945 | 2 |
| Stephen E Smith Md Pa | 8426031964 | 2 |
News Archive
In California, voters are split over a ballot initiative that would give the state's insurance commissioners new powers to veto health insurance cost increases. Meanwhile, in Iowa, the insurance commissioner approves rate increases proposed by three insurers.
NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet, Sinemet CR or Stalevo, in patients with advanced Parkinson's disease.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Biomarkers for Alzheimer's disease" to the Company.
SuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of SGI-110, a second-generation hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).
Science Applications International Corporation announced today that it was awarded a prime follow-on contract by the U. S. Department of Defense (DoD), Biometrics Identity Management Agency (BIMA) to continue providing biometric support services to the U.S. Central Command's (USCENTCOM) area of responsibility (AOR).
› Verified 2 days ago
| Entity Name | Stephen E Smith Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760442677 PECOS PAC ID: 8426031964 Enrollment ID: O20040608000197 |
News Archive
In California, voters are split over a ballot initiative that would give the state's insurance commissioners new powers to veto health insurance cost increases. Meanwhile, in Iowa, the insurance commissioner approves rate increases proposed by three insurers.
NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet, Sinemet CR or Stalevo, in patients with advanced Parkinson's disease.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Biomarkers for Alzheimer's disease" to the Company.
SuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of SGI-110, a second-generation hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).
Science Applications International Corporation announced today that it was awarded a prime follow-on contract by the U. S. Department of Defense (DoD), Biometrics Identity Management Agency (BIMA) to continue providing biometric support services to the U.S. Central Command's (USCENTCOM) area of responsibility (AOR).
› Verified 2 days ago
| Entity Name | Eye Associates Of Southwest Florida Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619937554 PECOS PAC ID: 7810234945 Enrollment ID: O20190129000502 |
News Archive
In California, voters are split over a ballot initiative that would give the state's insurance commissioners new powers to veto health insurance cost increases. Meanwhile, in Iowa, the insurance commissioner approves rate increases proposed by three insurers.
NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet, Sinemet CR or Stalevo, in patients with advanced Parkinson's disease.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Biomarkers for Alzheimer's disease" to the Company.
SuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of SGI-110, a second-generation hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).
Science Applications International Corporation announced today that it was awarded a prime follow-on contract by the U. S. Department of Defense (DoD), Biometrics Identity Management Agency (BIMA) to continue providing biometric support services to the U.S. Central Command's (USCENTCOM) area of responsibility (AOR).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen E Smith, MD 4225 Evans Ave, Fort Myers, FL 33901-9311 Ph: (239) 936-8655 | Dr Stephen E Smith, MD 4225 Evans Ave, Fort Myers, FL 33901-9311 Ph: (239) 936-8655 |
News Archive
In California, voters are split over a ballot initiative that would give the state's insurance commissioners new powers to veto health insurance cost increases. Meanwhile, in Iowa, the insurance commissioner approves rate increases proposed by three insurers.
NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet, Sinemet CR or Stalevo, in patients with advanced Parkinson's disease.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Biomarkers for Alzheimer's disease" to the Company.
SuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of SGI-110, a second-generation hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).
Science Applications International Corporation announced today that it was awarded a prime follow-on contract by the U. S. Department of Defense (DoD), Biometrics Identity Management Agency (BIMA) to continue providing biometric support services to the U.S. Central Command's (USCENTCOM) area of responsibility (AOR).
› Verified 2 days ago
Mark S Gorovoy, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 12381 S Cleveland Ave Ste 300, Fort Myers, FL 33907 Phone: 239-939-1444 Fax: 239-936-7710 | |
Nika Stephanie Priest-allen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6091 S Pointe Blvd, Fort Myers, FL 33919 Phone: 239-985-7171 Fax: 239-985-7118 | |
Dr. Katrina Angela Mears, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6901 International Center Blvd, Fort Myers, FL 33912 Phone: 239-939-4323 Fax: 239-939-3983 | |
Pierre Bourgon, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 9800 S Healthpark Dr, Suite 110, Fort Myers, FL 33908 Phone: 239-689-5000 Fax: 239-689-5007 | |
Boyd Vaziri, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9617 Gulf Research Ln, Fort Myers, FL 33912 Phone: 239-418-0999 Fax: 239-274-0773 | |
Syeda Sumara Taranum Basith, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9800 S Healthpark Dr Ste 110, Fort Myers, FL 33908 Phone: 239-343-6050 Fax: 239-343-6883 | |
Dr. John W Snead, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4790 Barkley Cir Bldg C-103, Fort Myers, FL 33907 Phone: 239-936-8686 Fax: 239-936-2532 |